Patents by Inventor Mary E. Neville

Mary E. Neville has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090130194
    Abstract: In one aspect, the present invention relates to methods of treating cancer in a patient comprising administering intravenously to a patient in need thereof a cancer treating effective amount of a lipid-complexed platinum compound composition wherein the concentration of the platinum compound of the lipid-complexed platinum compound composition is greater than about 1.2 mg/ml.
    Type: Application
    Filed: May 16, 2008
    Publication date: May 21, 2009
    Applicant: Transave, Inc.
    Inventors: Frank G. Pilkiewicz, Roman Perez-Soler, Walter R. Perkins, Yiyu Zou, Mary E. Neville, Jin K. Lee, Vladimir Malinin
  • Publication number: 20090105126
    Abstract: The present disclosure relates in part to methods of treating and prevention of pulmonary disorders in a subject in need thereof comprising administering to the subject a liposomal vancomycin compositions having low lipid to drug ratios and high concentration of vancomycin.
    Type: Application
    Filed: October 23, 2008
    Publication date: April 23, 2009
    Inventors: Xingong Li, Walter R. Perkins, Anthony Scotto, Mary E. Neville
  • Publication number: 20020051813
    Abstract: The invention describes a Lipomatrix composed of lipid lattices of stacked bilayers which, when hydrated, form liposomes. The invention also provides a simplified method used to generate highly effective liposomal preparations. Vaccine compositions having superior immunological properties use biomedical-grade liposomes which can be produced from a Lipomatrix, using safe and efficient methods. Use of the inventive methods produces highly potent vaccines against tumor antigens.
    Type: Application
    Filed: June 1, 2001
    Publication date: May 2, 2002
    Inventors: Lawrence Boni, Michael M. Batenjany, Richard J. Robb, Mircea C. Popescu, Mary E. Neville
  • Patent number: 5158941
    Abstract: This invention concerns the use of synthetic Lipid A analog P9132 to activate human monocytes, and inhibit growth of tumor cells.
    Type: Grant
    Filed: June 8, 1990
    Date of Patent: October 27, 1992
    Assignee: E. I. Du Pont de Nemours and Company
    Inventors: Prabhakar K. Jadhav, Mary E. Neville, Robert C. Newton, Subramaniam Sabesan